Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion

Yasutaka Murahashi(Sapporo Medical University), Taku Saito(The University of Tokyo)
Scientific Reports
December 30, 2019
Cited by 20


Related Papers